PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
24-Jan-2023 French Biotech Company AdipoPharma Secures Series A Funding for Groundbreaking Diabetes Drug AdipoPharma
24-Jan-2023 HUTCHMED Announces License to Takeda to Develop and Commercialize Fruquintinib Outside China HUTCHMED
24-Jan-2023  DEFENCE’S MELANOMA TARGETED VACCINE A1-REPROGRAMMED MSC (ARM) CELL POTENCY VALIDATED Defence Therapeutics Inc.
24-Jan-2023 BD to Highlight its Deep Commitment to Drug Delivery Innovation at Pharmapack B3C newswire
24-Jan-2023 Biotest AG: First patient treated with Cytotect® CP Biotest in study after heart and lung transplantation Biotest AG
23-Jan-2023 First-in-Human Clinical Data Shows SonoTran® is Safe and Well-Tolerated B3C newswire
23-Jan-2023 Defence Therapeutics Inc.:  DEFENCE TO PRESENT AT THE 9TH ANNUAL IMMUNO-ONCOLOGY 360º SUMMIT IN NEW-YORK FEBRUARY 7-10, 2023 Defence Therapeutics Inc.
23-Jan-2023 Stifel initiates research coverage of Xlife Sciences Xlife Sciences AG
20-Jan-2023 Evaxion receives FDA fast-track designation for personalized cancer immunotherapy Evaxion Biotech A/S
20-Jan-2023 TrakCel and AmerisourceBergen expand platform integration to facilitate patient care coordination for cell and gene therapies TrakCel
20-Jan-2023 BRUKINSA® (zanubrutinib) Receives Marketing Authorization for Chronic Lymphocytic Leukemia (CLL) and Marginal Zone Lymphoma (MZL) in Great Britain by MHRA BeiGene
20-Jan-2023 Beckman Coulter Life Sciences Completes First Phase of Colorado Research and Development Hub with Grand Opening of $10 Million Loveland Offices Beckman Coulter Life Sciences
20-Jan-2023 Weekly Pharma & Life Science News Round-Up: 16th – 20th January 2023 PharmiWeb.Jobs
20-Jan-2023 Xlife Sciences: Swiss portfolio company Axenoll receives strategically significant patent by the European Patent OfficeTitle Xlife Sciences AG
20-Jan-2023 COLTENE announces key figures for the 2022 financial year COLTENE Holding AG
19-Jan-2023 osteolabs Successfully Demonstrates Broader Application of its Technology for Chronic Kidney Disease and Bone Metastasis-related Prostate Cancer osteolabs
19-Jan-2023 Cool & homogeneous: Single Use Support introduces product innovation Single Use Support
19-Jan-2023 NICE recommends all-oral triplet regimen for patients living with relapsed or refractory multiple myeloma Takeda UK Ltd.
19-Jan-2023 osteolabs Successfully Demonstrates Broader Application of its Technology for Chronic Kidney Disease and Bone Metastasis-related Prostate Cancer B3C newswire
19-Jan-2023 SOTIO Doses First Patient in AURELIO-05 Phase 2 Trial of Nanrilkefusp Alfa in Combination with Cetuximab B3C newswire